Main Industry
Biotechnology
Main Product/Service
1. AJ201
2. AJ302
3. AJ303
2. AJ302
3. AJ303
Founded Year
2014
Unified Business No.
24777699
Status
Active
Number of Employees
0
Total Paid-in
Capital
1,009,390,390 (NT$)
Location of Company
Taiwan
, Taipei City
Exit Status
Emerging Stock Exchange(2025)
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
AnnJi Pharmaceutical is a clinical-stage drug development company that specializes in developing small molecules that address unmet medical needs in the areas of neurology, dermatology, and inflammatory disorders, including rare diseases such as idiopathic pulmonary fibrosis and Kennedy’s disease, and SBMA (Spinal and bulbar muscular atrophy). Thefocus of the company is on creating global collaborations and business partnerships in the late-stage product development and commercialization of pharmaceutical drugs.
